miRNAs modulate the PI3K/Akt/mTOR pathway in HCC either as oncomiRs or tumor suppressor miRNAs, thereby influencing tumor progression, metastasis, and treatment responses. The gene discussed is AKT1; the disease is hepatocellular carcinoma.